Diagnostic predictors of Legionella pneumonia in Japan

J Infect Chemother. 2018 Mar;24(3):159-163. doi: 10.1016/j.jiac.2017.12.009. Epub 2018 Feb 2.

¹ Department of Internal Medicine 1, Kawasaki Medical School, Okayama, Japan. Electronic address: nao@med.kawasaki-m.ac.jp.
² Department of Pulmonology, Yokohama City University Graduate School of Medicine, Japan.
³ National Hospital Organization Okinawa National Hospital, Japan.
⁴ Department of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Japan.
⁵ Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Japan.
⁶ Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, Japan.
⁷ Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Japan.
⁸ Taisho Toyama Pharmaceutical Co., Ltd, Japan.
⁹ Daiichi Sankyo Co., Ltd, Japan.
¹⁰ Department of Urology, The Jikei University Katsushika Medical Center, Japan.
¹¹ Research Division for Development of Anti-Infective Agents, Institute of Development, Aging and Cancer, Tohoku University, Japan.

No abstract available

Keywords: C-reactive protein; Community-acquired pneumonia; Diagnostic predictors; Legionella; Serum sodium.

MeSH terms